We studied death 
Introduction
Cell death is a prominent component of the human atherosclerotic plaque with areas of "necrosis" being present in over 80% of primary lesions (1, 2) . Ultimately, the morbidity and mortality associated with atherosclerosis results from rupture of the plaque into this "necrotic" area, with thrombosis leading to both ischemia and infarction (3) . Cell death is also present in animal models of atherosclerosis. In fat-fed swine, for instance, one of the most well-characterized models of cell kinetics in atherosclerosis, cell death is present at all stages of lesion development (4) (5) (6) . In the early lesions in this model, cell vasculature has previously been thought to be due to direct toxic insult, as a reaction to free radical generation or peroxidation from oxidised lipids, for instance (7, 8) . However, recent evidence has indicated that cell death of endothelial cells (9) , VSMCs (10) , and macrophages (11) may all occur via the highly regulated process of programmed cell death, or apoptosis.
Apoptosis is a ubiquitous, evolutionarily conserved, physiological mechanism of cell death that regulates tissue mass and architecture in many tissues ( 12) . The genetic program for cell death, which is contained in selected or even all cells, may be activated at a defined time during embryogenesis or in the maturation of adult cells, by a wide range of physiological and pharmacological stimuli. In VSMCs, for example, we have identified apoptosis in the presence of deregulated expression of the c-myc protooncogene (10, 13) . Deregulated expression of c-myc has previously been demonstrated to occur in one study of cultured human plaque VSMCs (14) . The present study examined VSMCs derived from human coronary atheromatous plaques and from normal vessels for the presence of apoptosis. Our data demonstrate that passaged plaque VSMCs have a markedly elevated rate of apoptosis in vitro. Apoptosis of human VSMCs can be partially reversed by expression of the classical antiapoptotic gene bcl-2 or by gene products normally present in the arterial wall, IGF-1 and PDGF.
Methods
Cell culture. Normal human VSMCs were derived from the media of the thoracic aorta of donors for cardiac transplantation (four cultures) and from the media of coronary arteries of recipients undergoing transplantation for nonischemic cardiomyopathy (four cultures). Patients were in the University of Washington Medical Center transplantation program from 1987 to 1994. Vessels were dissected from the heart, a piece of vessel taken for routine histology, and cells prepared by enzyme digestion of pieces of media. Briefly, arteries were predigested with an enzyme mix containing 165 U/ml collagenase type I, 15 U/ml elastase type HI, 0.375 ng/ml of soybean trypsin inhibitor in serum-free Waymouth's medium for 20 min at room temperature. The vessels were then cut open and pinned luminal side up on a dissecting surface. The residual endothelium was removed with a plastic cell scraper and the media and intima separated by peeling the intima from the media. Medial tissue was then minced and digested in the enzyme mix for 16 (10) . Passage four through six cells were plated in 10-cm-diameter dishes at 2 x 107 cells/dish in normal tissue culture medium and infected using the retrovirus constructs. Cell plates were split 1:50 and cells were selected in medium containing 750 jig/ml of the neomycin analogue G418 (GIBCO, Grand Island, NY). After 1 wk of antibiotic treatment, isolated surviving single cells were evident on culture plates. Clones of resistant cells containing bcl-2 were ring cloned after 4-6 wk and both clones and an uncloned population were cultured in medium containing G418 thereafter. Clones of bcl-2-infected cells and cell populations were each tested individually and compared against a pooled population of cells infected with the vector alone. Cells were maintained in neomycin at all times and used for experiments after a minimum of 4 wk in selection.
Analysis of cell number andflow cytometry. Cells were plated into 24-well plates at 1 x 104 cells/well in medium containing 20% FCS and growth of cultures were analyzed by cell counts over 10 d of cells that could exclude trypan blue. Cell cycle distribution of cells in culture in 20% FCS was determined by flow cytometric analysis as previously described (10) .
Time-lapse videomicroscopy. Cells were prepared for videomicroscopy as previously described (10) . Briefly, cells were maintained in medium containing 20% FCS, washed three times in medium containing 0% FCS, and then cultured in this latter medium. This was supplemented with selenite (30 nM), transferrin (5 jig/ml), fibronectin (1 Ag/ml), and albumin (1 mg/ml). Flasks were gassed with 95% air and 5% CO2 every 24 h and sealed. The microscope was enclosed in a plastic environment chamber and maintained at 37°C by an external heater.
The time-lapse equipment consisted of a camera (Dage-MTI Inc., Michigan, IN) and Panasonic 8050 time-lapse video recorder with Colorado video synchronization system (Colorado Video, Boulder, CO). Films were analyzed for morphology of apoptosis and cell death rates as previously described (10, 13, 16) using an observer blind to cell type and treatment conditions. Cell division was scored at the time at which septa appeared between two daughter cells and intermitotic time measured between divisions of successive generations derived from the same cell over an extended period (7-10 d RNA isolation and Northern hybridization. RNA was extracted from individual cultures of normal and plaque VSMCs cultured in 20% FCS and from RL-7 cells, a human B-cell lymphoma cell line that has a t( 14;18) chromosomal translocation and that overexpresses bcl-2. Total RNA from 10' cells was isolated using the method of Chirgwin et al. (17) . RNA was fractionated, transferred, and hybridized as previously described (18) using a random primed human bcl-2 probe, SFFV-bcl-2 (15), and a random primed 28S probe to verify equal loading of RNA.
Immunocytochemical analysis for Bcl-2 protein. VSMCs were plated onto eight-well Tissue-Tek slides (Nunc, Naperville, IL) at 3,000 cells/well and cultured for 48 h. Cells were fixed and processed for immunocytochemistry as previously described (10) . Briefly, cells were washed three times in PBS, fixed in 4% paraformaldehyde in PBS at room temperature for 15 min, and blocked using incubation buffer (PBS, 1% BSA, 0.5% Triton X-100, 0.02% sodium azide) for 30 min at room temperature. Bcl-2 protein was detected using a hamster monoclonal antibody 6C8 antibody (15) diluted to 1 ug/ml in incubation buffer and bound antibody visualized using a biotin-labeled horse anti-hamster antibody at 1:200 dilution and an avidin-biotin peroxidase detection system (Vector Labs, Burlingame, CA).
Statistical analyses. The means of apoptotic deaths were analyzed using ANOVA for multiple comparisons. Paired analysis between two groups, between plaque and normal VSMCs, or between uninfected and bcl-2-infected cell lines, for instance, was performed using Student's t-test where ANOVA indicated significance for the multiple comparison.
Results
Human VSMC cultures were obtained from coronary plaques (plaque VSMCs) and from the media of normal coronary arteries and aorta ( "normal" VSMCs). Cultures were obtained from specimens from individual patients of both sexes and from a range of ages (Table I) . Mean age of patients was 49.8 yr (plaque), 41.8 yr (normal aorta), and 47.8 yr (normal coronary artery); these differences were not significant. Atherectomy specimens were from primary lesions only, which had not received previous intervention. Three out of five atherectomy specimens were from patients who were experiencing unstable angina, although by passages four through six no significant The proliferation ofhuman VSMCs in culture. Before analysis of cell death of the human VSMC cultures, baseline kinetic parameters of each culture were determined at passage five and six. The rate of increase of cell number over time was analyzed in each cell type by cell counts, and the cell cycle distribution by flow cytometric analysis. This indicated that plaque-derived cells showed a significantly slower increase in cell number than cells derived from nonatherosclerotic aorta or coronary artery (Fig. 1) . Consistent with this observation, the percentage of cells in S-phase in the plaque cell cultures in medium containing 20% FCS was significantly less than that of the normal cells (Table II) . The intermitotic time of individual cells, assessed by extended time-lapse videomicroscopy, indicated that plaque- derived cells had a longer mean intermitotic time than both normal cell types (Table II) . There was no significant difference in the growth parameters of human VSMCs derived from the media of coronary arteries or from the aorta. Cell death ofnormal and plaque-derived VSMCs. Videomicroscopy of plaque and normal coronary and aortic VSMCs indicated a marked difference in the frequency of cell death between the cell types. Cells from normal coronary arteries or aorta did not undergo spontaneous cell death when cultured in 20% FCS. However, 2.7±0.5% (mean±SEM) of aortic cells and 3.25±0.4% of normal coronary cells died over 24 h in 0% FCS (Fig. 2) . In contrast, plaque-derived cells showed a significantly higher rate of spontaneous cell death in 20% FCS over 24 h (8.7±1.8%) and this increased to 16 .8±2.7% in low serum. Cells were analyzed for rates of apoptosis in subconfluent culture, between passages four and six. However, there was no significant difference in the rate of cell death between these passages of the same culture (not shown). Death in all cell types exhibited rapid, sequential, morphological changes indicative of apoptosis ( 10, 16, 19) (Fig. 3) . Cells first retracted from their neighbors and shrunk in size. This was followed by intense membrane blebbing and the formation of membranebound vesicles. The end product was a dense apoptotic body, which in some cases was seen to be phagocytosed by adjacent cells. These appearances were confirmed on electron microscopy (Fig. 4, A-D) , which in addition demonstrated peripheral chromatin condensation in association with the intense membrane activity. When DNA was extracted from cells in the culture supernatant, a nucleosome ladder pattern, indicative of internucleosomal cleavage, was evident in plaque cells in low and high serum and in normal VSMCs in low serum conditions ( Fig. 5) . This is consistent with apoptosis observed by timelapse videomicroscopy in plaque VSMCs in low and high serum but only in normal VSMCs in low serum (Fig. 2) (Fig. 6, A and B) . In plaque-derived VSMCs, the antiapoptotic effects of IGF-1I and PDGF were titratable and observed at levels similar to those at which each cytokine is mitogenic (10-100 and 1-10 ng/mi, respectively) (Fig. 6 A) . In lower rate of apoptosis in these cells, this was significant only at the 10-100-ng/ml dose range for IGF-1 and 100 ng/ml for PDGF-BB. The data for normal coronary VSMCs are shown in Fig. 6 (20) (21) (22) (23) , there was no obvious relationship between the potency of mitogenic action of a growth factor and its ability to suppress cell death. The effect ofbcl-2 expression on VSMC apoptosis. To investigate the effect of overexpression of bcl-2 on VSMC apoptosis, normal and plaque-derived VSMCs were infected with a retrovirus vector encoding human bcl-2 or the vector alone. Resistant cell populations were pooled after > 4 wk selection in medium containing G418. In addition, clones of bcl-2-infected cells were obtained after 6-8 wk in culture. The rate of apoptotic death in cells containing bc1-2 or the vector alone was assessed by time-lapse videomicroscopy. Infection with bcl-2 suppressed apoptosis of normal VSMCs in low serum conditions and partially suppressed apoptosis of plaque-derived cells in both low and high serum conditions (Fig. 7 A) . Clones of bcl-2-infected cells and the pooled populations of resistant cells behaved similarly (not shown). Cells containing the vector alone had similar rates of apoptosis as uninfected cells (Fig. 7 B) , indicating that the protective effect of bcl-2 was not due to selection of cells with a decreased capacity to die in culture. Bcl-2 infection did not immortalize the cultures of VSMCs, although it did prolong the lifespan of plaque cultures by approximately two to three passages. This effect was due to suppression of cell death alone, as bcl-2 infection had no effect on the intermitotic time of plaque cells (Table II) or the percentage of cells within the population that underwent mitosis (not shown).
The expression of bcl-2 in normal and plaque-derived VSMCs. Constitutive expression of bcl-2 in human plaque-derived VSMCs reduced rates of cell death to almost those seen in cells derived from normal vessels. To examine whether expression of bcl-2 per se could account for the differences in apoptotic rates observed between normal and plaque cells, we assessed bcl-2 expression in normal aortic VSMCs and plaquederived cells by Northern hybridization and immunocytochemistry. Bcl-2 mRNA was not detectable on Northern hybridization from either plaque-derived or normal aortic VSMCs (Fig. 8) . In addition, Bcl-2 protein was not seen on immunocytochemistry in VSMCs derived from plaques or normal aorta (Fig. 9 with the bc1-2 retrovirus vector. In infected cells, Bcl-2 was evident as a characteristic punctate cytoplasmic staining in the cytoplasm and around the periphery of the nucleus as previously described (Fig. 9) (15, 24) . As Bcl-2 protected against apoptosis at levels that were easily detectable by immunocytochemistry and bc1-2 suppressed apoptosis in both plaque-derived and normal VSMCs, the differences we observe between rates of apoptosis in plaque and normal VSMCs are unlikely to be due to differences in endogenous Bcl-2 expression.
Discussion
We report a marked difference in spontaneous cell death in cultures of smooth muscle cells derived from human coronary atheromatous plaques as compared with cells derived from the normal vessel wall. This cell death has the characteristic mor-C.
. . B S S e (13) . We therefore consider this possibility unlikely.
Cell death in plaques has previously been presumed to be due to direct toxicity of local factors, for example, oxidized lipids. However, as culture conditions of cells derived from plaques or normal vessels were identical and cells were separated from other components of the plaque, the higher death rate of plaque cells we observe implies that these VSMCs possess an innate susceptibility to cell death. As plaques show evidence of monoclonality (25) , suggesting that they have arisen from a subpopulation of cells within the arterial wall, this susceptibility may be intrinsic to a cell lineage from which the plaque developed, may be acquired during atherogenesis, or both. Apoptosis in mammalian cells has been shown to be regulated by the expression of specific gene products, many of which are transcription factors (for review see reference 26). Indeed, we have previously shown that apoptosis in VSMCs may be regulated by expression of the c-myc protooncogene (10, 13) . Here we show that human VSMC apoptosis is suppressed by expression of the protooncogene bcl-2. Bcl-2 is a membrane-associated protein that suppresses apoptosis in some cell types and after some injurious agents (27) , including c-myc-induced apoptosis in VSMCs (our unpublished observations) and fibroblasts (28) .
The mechanism of bcl-2 action is unknown, but bcl-2 expression can inhibit apoptosis due to free radicals and lipid peroxidation (29), both of which are implicated in atherogenesis (8) . Thus, it is conceivable that higher rates of apoptosis in plaque VSMCs is the result of some heritable presumably genetic change produced by exposure to oxidized lipids and other free radicals. (30) (31) (32) . This has been taken as evidence that plaque VSMCs may have undergone more doublings in vivo than cells from normal arteries. Our observations indicate that failure of plaque cell culture is at least partly due to cell death. The reported shortened lifespan of plaque VSMCs in culture may therefore be due to the greater number of cell doublings required to produce passageable cell numbers in the presence of a higher apoptotic rate.
The proportion of cells that underwent apoptosis did not change significantly in plaque-derived cells cultured in 20% FCS over passages four through six. This is despite a fairly constant rate of cell death of 7-8%/d. We have previously observed that in a clonal cell line of smooth muscle cells (VSMmyc cells, rat smooth muscle cells possessing deregulated expression of the c-myc protooncogene [10] ) that is forced to undergo repeated rounds of apoptosis, the remaining cells undergo apoptosis at the same rate throughout (our unpublished observations). This argues that apoptosis in our VSMC cultures may be a stochastic process, an ability possessed by all cells in the culture and not limited to a particular subset of smooth muscle cells. This does not, of course, preclude the possibility that a subset of VSMCs is present in the vessel wall possessing an increased susceptibility to apoptosis.
We also investigated the role of specific growth factors present in serum to regulate apoptosis of human VSMCs. We show that normal human VSMCs undergo apoptosis upon serum removal, and death can be suppressed by addition of IGF-I and to a lesser extent PDGF. This is consistent with recent findings indicating that IGF-l and PDGF are potent survival factors for both rat fibroblasts and VSMCs when death is induced by the c-myc protooncogene (10, 13) . The requirement for survival factors indicates that cells of the normal vessel wall require constant exposure to such factors to maintain viability. Although we have demonstrated this requirement in vitro, the presence of growth factors in the vessel wall in vivo may also be necessary for cell survival.
In contrast to normal VSMCs, plaque VSMCs show spontaneous cell death, even in the presence of high concentrations of serum survival factors, and death is further promoted by serum removal. Thus, apoptosis may occur in vivo in plaques even when cells are constantly exposed to high concentrations of survival cytokines. Given the absence of elevated rates of VSMC replication in plaques (33, 34) , even in those plaques that contain increased amounts of growth factors, our data suggest that growth factors present in lesions might be important to stabilize lesions rather than promoting growth of the plaque. Thus, cell loss via apoptosis may ultimately predispose to plaque fissuring or rupture, events closely associated with major clinical sequelae such as thrombosis and myocardial infarction (35) .
Although higher rates of apoptosis may be a pathological property of plaque VSMCs, apoptosis is also a homeostatic mechanism of maintaining cell number, particularly important in development and tissue remodeling. Our findings suggest that apoptosis may be a principal regulator of cell number in the vessel wall, balancing cell proliferation and thus helping to maintain vessel wall architecture. In support of this hypothesis is recent evidence indicating that apoptosis is a major determinant of VSMC cell number in the arterial wall after birth, where major remodeling occurs due to changes in blood flow (36 VSMC birth and death rates seen in normal arteries (4), a link that may be lost upon development of atherosclerosis. Changes in the rates of cell death may therefore be a mechanism by which cells accumulate or are lost, irrespective of any changes in proliferation.
In conclusion, we have demonstrated that human VSMCs derived from normal vessels and atheromatous plaques undergo apoptosis, particularly upon removal of serum survival factors. Apoptosis may be suppressed by expression of bcl-2 or the addition of specific survival cytokines, indicating that apoptosis of VSMCs is regulated by the expression of specific gene products and by the local cytokine environment. Apoptosis may therefore be a mechanism of regulating cell number in the normal arterial wall and contribute to the pathogenesis of atherosclerosis.
